He said the biotechnology science has made such a remarkable progress in Iran that 97 percent of the pharmaceutical products are being made inside the country.
For a brief review of Iran’s achievements in various fields of science and technology, check the book “Science and Technology in Iran: A Brief Review – 2019”
The vice president then explained that science, including the biotechnology, could not be purchased through state-funded universities, noting that income will be generated when knowledge-based companies grow and be able to sell their technologies.
He finally highlighted the ample opportunities for biotechnology-related research and development in the coastal province of Bushehr, saying the knowledge-based enterprises could work on maritime biotechnology with a focus on microalgae.
In remarks in July, Sattari said Iran had plans for special support for medicine and vaccines needed for livestock and poultry, pointing to the advancement of local knowledge-based companies in biotechnology, human and animal medicine, and vaccines.